Summit Therapeutics shares owned by Mirae Asset Global Etfs Holdings
Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Mirae Asset Global Etfs Holdings
from 13F filings
Historical chart of Mirae Asset Global Etfs Holdings investment in Summit Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Summit Therapeutics held by Mirae Asset Global Etfs Holdings consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Summit Therapeutics by Mirae Asset Global Etfs Holdings
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $381k | 18k | 21.16 |
| 2025-06-30 | $219k | 10k | 21.28 |
| 2025-03-31 | $1.3M | 65k | 20.32 |
| 2024-12-31 | $1.2M | 65k | 17.89 |
| 2024-09-30 | $1.1M | 52k | 21.90 |
| 2024-06-30 | $506k | 65k | 7.80 |
More positions owned by Mirae Asset Global Etfs Holdings
View all positions for Mirae Asset Global Etfs Holdings